Astrana Health (ASTH) Competitors $42.08 +1.04 (+2.53%) (As of 11:27 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends ASTH vs. GLOB, HQY, BILI, MARA, LYFT, QXO, ETSY, NVEI, TNET, and ALITShould you be buying Astrana Health stock or one of its competitors? The main competitors of Astrana Health include Globant (GLOB), HealthEquity (HQY), Bilibili (BILI), MARA (MARA), Lyft (LYFT), QXO (QXO), Etsy (ETSY), Nuvei (NVEI), TriNet Group (TNET), and Alight (ALIT). These companies are all part of the "business services" industry. Astrana Health vs. Globant HealthEquity Bilibili MARA Lyft QXO Etsy Nuvei TriNet Group Alight Globant (NYSE:GLOB) and Astrana Health (NASDAQ:ASTH) are both mid-cap computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, community ranking, institutional ownership, analyst recommendations, profitability and media sentiment. Is GLOB or ASTH more profitable? Globant has a net margin of 7.20% compared to Astrana Health's net margin of 3.63%. Globant's return on equity of 11.65% beat Astrana Health's return on equity.Company Net Margins Return on Equity Return on Assets Globant7.20% 11.65% 7.88% Astrana Health 3.63%9.37%5.32% Does the MarketBeat Community favor GLOB or ASTH? Globant received 376 more outperform votes than Astrana Health when rated by MarketBeat users. However, 84.62% of users gave Astrana Health an outperform vote while only 60.09% of users gave Globant an outperform vote. CompanyUnderperformOutperformGlobantOutperform Votes38760.09% Underperform Votes25739.91% Astrana HealthOutperform Votes1184.62% Underperform Votes215.38% Do institutionals and insiders hold more shares of GLOB or ASTH? 91.6% of Globant shares are held by institutional investors. Comparatively, 52.8% of Astrana Health shares are held by institutional investors. 2.7% of Globant shares are held by company insiders. Comparatively, 8.5% of Astrana Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more risk & volatility, GLOB or ASTH? Globant has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500. Comparatively, Astrana Health has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500. Do analysts recommend GLOB or ASTH? Globant presently has a consensus target price of $229.06, indicating a potential upside of 4.32%. Astrana Health has a consensus target price of $65.17, indicating a potential upside of 54.86%. Given Astrana Health's stronger consensus rating and higher possible upside, analysts plainly believe Astrana Health is more favorable than Globant.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Globant 1 Sell rating(s) 6 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.58Astrana Health 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has preferable valuation and earnings, GLOB or ASTH? Globant has higher revenue and earnings than Astrana Health. Astrana Health is trading at a lower price-to-earnings ratio than Globant, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlobant$2.35B4.02$158.54M$3.8357.33Astrana Health$1.39B1.71$60.72M$1.3032.37 Does the media refer more to GLOB or ASTH? In the previous week, Globant had 37 more articles in the media than Astrana Health. MarketBeat recorded 45 mentions for Globant and 8 mentions for Astrana Health. Astrana Health's average media sentiment score of 1.23 beat Globant's score of 0.56 indicating that Astrana Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Globant 12 Very Positive mention(s) 8 Positive mention(s) 13 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Astrana Health 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryGlobant beats Astrana Health on 13 of the 19 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get Astrana Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ASTH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASTH vs. The Competition Export to ExcelMetricAstrana HealthManagement consulting services IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.31B$2.55B$5.03B$8.81BDividend YieldN/A2.60%5.16%4.06%P/E Ratio31.578.95135.4117.82Price / Sales1.6625.481,160.9774.56Price / Cash29.9115.6933.5332.53Price / Book3.883.324.674.68Net Income$60.72M$126.36M$119.07M$226.08M7 Day Performance-2.05%-2.20%-1.83%-1.04%1 Month Performance-31.73%-9.23%-3.60%1.04%1 Year PerformanceN/A-8.21%31.66%26.28% Astrana Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASTHAstrana Health3.8895 of 5 stars$42.08+2.5%$65.17+54.9%N/A$2.37B$1.39B32.371,800Positive NewsGLOBGlobant4.0595 of 5 stars$219.57+1.8%$229.06+4.3%+3.0%$9.46B$2.35B56.3229,150Analyst ForecastHQYHealthEquity3.6708 of 5 stars$103.14+0.2%$107.23+4.0%+54.3%$9.01B$999.59M85.803,150News CoverageBILIBilibili2.2522 of 5 stars$18.74-2.3%$19.69+5.1%+31.7%$7.77B$3.19B-20.868,801Earnings ReportAnalyst ForecastGap DownMARAMARA2.7606 of 5 stars$23.69+4.7%$22.88-3.4%+112.7%$7.62B$387.51M29.439Analyst ForecastInsider TradeOptions VolumeGap UpLYFTLyft3.9777 of 5 stars$16.66-0.7%$17.48+4.9%+61.4%$6.91B$4.40B0.002,945QXOQXO0.9892 of 5 stars$16.46+2.9%N/AN/A$6.74B$54.52M-1.75195News CoverageETSYEtsy4.6169 of 5 stars$51.59+1.4%$64.87+25.7%-29.4%$5.80B$2.75B25.952,420NVEINuvei1.6818 of 5 stars$33.99+0.0%$32.08-5.6%+72.3%$4.82B$1.19B226.602,202Dividend AnnouncementHigh Trading VolumeTNETTriNet Group4.2848 of 5 stars$92.66-1.6%$117.00+26.3%-15.2%$4.59B$4.97B18.163,600Analyst ForecastPositive NewsALITAlight3.532 of 5 stars$7.84+1.2%$10.95+39.7%+3.4%$4.28B$3.41B-16.1418,000Insider Trade Related Companies and Tools Related Companies Globant Competitors HealthEquity Competitors Bilibili Competitors MARA Competitors Lyft Competitors QXO Competitors Etsy Competitors Nuvei Competitors TriNet Group Competitors Alight Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ASTH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astrana Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astrana Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
